about
Nanoparticles for brain drug deliveryHow drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusionExosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challengesRegeneration strategies after the adult mammalian central nervous system injury-biomaterialsThe biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?Reassessing the Role of Intra-Arterial Drug Delivery for Glioblastoma Multiforme TreatmentStrategies for regeneration of components of nervous system: scaffolds, cells and biomoleculesPromising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studiesPhysiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug deliveryEngineered nanomaterial uptake and tissue distribution: from cell to organismMovement of magnetic nanoparticles in brain tissue: mechanisms and impact on normal neuronal functionTrafficking of Endogenous Immunoglobulins by Endothelial Cells at the Blood-Brain Barrier.Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain MetastasesAnti-Inflammation of Natural Components from Medicinal Plants at Low Concentrations in Brain via Inhibiting Neutrophil Infiltration after StrokeExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsLactate as a Metabolite and a Regulator in the Central Nervous SystemEvolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.The molecular constituents of the blood-brain barrierExposure to lipophilic chemicals as a cause of neurological impairments, neurodevelopmental disorders and neurodegenerative diseasesBioPPSy: An Open-Source Platform for QSAR/QSPR AnalysisIBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CAOral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model.Localized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasoundPenetrating the Blood-Brain Barrier: Promise of Novel Nanoplatforms and Delivery Vehicles.Efficient Enhancement of Blood-Brain Barrier Permeability Using Acoustic Cluster Therapy (ACT).Characterizing Focused-Ultrasound Mediated Drug Delivery to the Heterogeneous Primate Brain In Vivo with Acoustic Monitoring.Focused ultrasound-mediated drug delivery through the blood-brain barrier.The size of blood-brain barrier opening induced by focused ultrasound is dictated by the acoustic pressure.Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness.The endothelial cell: an "early responder" in the development of insulin resistance.Drug delivery across the blood-brain barrier using focused ultrasound.Noninvasive and targeted drug delivery to the brain using focused ultrasound.Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive propertiesBiomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-Art, challenges, and opportunities for studying brain chemistry.Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of StrokeFNDC5/irisin - their role in the nervous system and as a mediator for beneficial effects of exercise on the brain.Pathways for small molecule delivery to the central nervous system across the blood-brain barrier.Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy
P2860
Q21285117-680E3D57-3139-4B77-A4C3-C95F27E66AF7Q24273350-16C1D426-0B81-4E57-966E-0F97D064D063Q26740577-76234540-0CF6-4BF5-B750-D228BA22A6EAQ26752004-EFF42D64-27D4-4281-BD8F-865F8BD78C29Q26753140-022B4030-F24B-4CB5-9A52-85A3B14B2F61Q26773083-694288BA-8FFD-49E6-81B7-767D7A5B5108Q26774324-F39AF745-4D92-483C-A82B-105D93E7A5A0Q26778701-2BE2FC66-781A-4360-B098-F99846A30B74Q26820289-E118071D-6971-423B-8FC5-6D854C7D20FDQ26861408-A56A15BC-AC85-495A-8E90-3C20857829A5Q26861914-51583268-3C02-4B13-9A97-7FDA02525F65Q27308522-B5BC66F6-6CFE-437F-8037-EEE94BF32F40Q27316624-45EDA7C0-A675-4CE7-874D-A8DFD8DF87DEQ27690256-EAD49EF7-9BAE-4A34-A31F-1990DDE0B757Q28072442-C544E677-0E40-4549-A5E0-0A87D1533A47Q28072829-60202833-2A60-4A52-979E-537E79961BF7Q28075692-539A055F-A470-4920-83FC-43D576423E6AQ28077766-CAF5FA2A-16C4-491B-96B6-6FCC4DEF0DC1Q28082016-D74FAE40-E490-4CF7-8C81-C3A8FA9D325CQ28087222-3BAF65B3-97F7-4918-83D6-DDD7BB7B7764Q28382950-3F3C54A7-CCA4-46EB-8F07-20276EB21052Q28553456-475F422B-275E-4844-AFAE-4215F97586BDQ28660580-F02757A8-0A7B-4822-B12D-6F5B4FDBE81FQ30277388-EFCBF045-7A67-4DED-B863-3DE0C9A1BD9BQ30362081-357C330C-23C0-4B14-A392-82EDE1FECE7DQ30365829-2ED3A3D1-BD4E-4ACE-9D32-402F6C16DEDEQ30367065-61C26601-34AE-47A4-9E0E-7D6F0A59E17AQ30369301-6B577060-87F5-4783-A5CE-0C329A7C58A0Q30394357-0AD9D6E9-A3B9-4768-930F-E22CB8D31504Q30407897-DC22FAB4-22E5-4C4E-9FC6-1AD4066B1936Q30411312-A4B95158-064C-4F49-A15B-E70505D43FE7Q30414637-68D78549-9E5E-4492-9E8E-6DE93AC0D51BQ30414698-508F5ED3-3620-4F9A-A4CF-08D0A582EB21Q30439968-DDB7AB45-685C-4F4F-ABB3-A7049D417EDBQ30572687-3E1CD81F-DE36-41AD-A8A4-D53EDA71E1F3Q31158600-23BECF94-1775-425F-925A-964FFCA4A1B6Q33565967-6DB31A50-7D4E-4D74-8D13-77B16CBD7153Q33643116-32F9C0AE-BD9B-4208-889C-A32A4F8CF998Q33783748-FC90180D-8103-410E-B6DA-141F0A3CE26CQ33786251-A676F00D-3BC2-42D3-BBED-356E3DC87102
P2860
description
article
@en
im November 2012 veröffentlicher wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2012
@uk
name
Drug transport across the blood-brain barrier
@en
Drug transport across the blood-brain barrier
@nl
type
label
Drug transport across the blood-brain barrier
@en
Drug transport across the blood-brain barrier
@nl
prefLabel
Drug transport across the blood-brain barrier
@en
Drug transport across the blood-brain barrier
@nl
P2860
P356
P1476
Drug transport across the blood-brain barrier
@en
P2860
P304
P356
10.1038/JCBFM.2012.126
P407
P577
2012-11-01T00:00:00Z